Cargando…
Does cefiderocol heteroresistance explain the discrepancy between the APEKS-NP and CREDIBLE-CR clinical trial results?
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743357/ https://www.ncbi.nlm.nih.gov/pubmed/35544102 http://dx.doi.org/10.1016/S2666-5247(21)00271-8 |
_version_ | 1784848708244865024 |
---|---|
author | Choby, Jacob E Ozturk, Tugba Satola, Sarah W Jacob, Jesse T Weiss, David S |
author_facet | Choby, Jacob E Ozturk, Tugba Satola, Sarah W Jacob, Jesse T Weiss, David S |
author_sort | Choby, Jacob E |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9743357 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
record_format | MEDLINE/PubMed |
spelling | pubmed-97433572022-12-12 Does cefiderocol heteroresistance explain the discrepancy between the APEKS-NP and CREDIBLE-CR clinical trial results? Choby, Jacob E Ozturk, Tugba Satola, Sarah W Jacob, Jesse T Weiss, David S Lancet Microbe Article 2021-12 2021-10-28 /pmc/articles/PMC9743357/ /pubmed/35544102 http://dx.doi.org/10.1016/S2666-5247(21)00271-8 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article under the CC BY-NC-ND 4.0 license. |
spellingShingle | Article Choby, Jacob E Ozturk, Tugba Satola, Sarah W Jacob, Jesse T Weiss, David S Does cefiderocol heteroresistance explain the discrepancy between the APEKS-NP and CREDIBLE-CR clinical trial results? |
title | Does cefiderocol heteroresistance explain the discrepancy between the APEKS-NP and CREDIBLE-CR clinical trial results? |
title_full | Does cefiderocol heteroresistance explain the discrepancy between the APEKS-NP and CREDIBLE-CR clinical trial results? |
title_fullStr | Does cefiderocol heteroresistance explain the discrepancy between the APEKS-NP and CREDIBLE-CR clinical trial results? |
title_full_unstemmed | Does cefiderocol heteroresistance explain the discrepancy between the APEKS-NP and CREDIBLE-CR clinical trial results? |
title_short | Does cefiderocol heteroresistance explain the discrepancy between the APEKS-NP and CREDIBLE-CR clinical trial results? |
title_sort | does cefiderocol heteroresistance explain the discrepancy between the apeks-np and credible-cr clinical trial results? |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743357/ https://www.ncbi.nlm.nih.gov/pubmed/35544102 http://dx.doi.org/10.1016/S2666-5247(21)00271-8 |
work_keys_str_mv | AT chobyjacobe doescefiderocolheteroresistanceexplainthediscrepancybetweentheapeksnpandcrediblecrclinicaltrialresults AT ozturktugba doescefiderocolheteroresistanceexplainthediscrepancybetweentheapeksnpandcrediblecrclinicaltrialresults AT satolasarahw doescefiderocolheteroresistanceexplainthediscrepancybetweentheapeksnpandcrediblecrclinicaltrialresults AT jacobjesset doescefiderocolheteroresistanceexplainthediscrepancybetweentheapeksnpandcrediblecrclinicaltrialresults AT weissdavids doescefiderocolheteroresistanceexplainthediscrepancybetweentheapeksnpandcrediblecrclinicaltrialresults |